Human Apolipoprotein A-IV
Open Access
- 1 April 1980
- journal article
- research article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 65 (4) , 911-919
- https://doi.org/10.1172/jci109745
Abstract
The role of the human intestine has been explored as a site of synthesis of apoA-IV, a major apoprotein of human intestinal triglyceride-rich lipoproteins. Intestinal biopsies were performed on normal volunteers while fasting and after lipid ingestion. Indirect immunofluorescence demonstrated a marked increase in immunofluorescence for apoA-IV during lipid absorption consistent with an increased intracellular content. ApoA-IV comprised 10-13% of chylomicron apoprotein and 24-30% of intestinal very low density lipoprotein (VLDL) as assessed by densitometry of sodium dodecyl sulfate gels of lipoproteins from chylous urine (mesenteric lymphatic-urinary fistula) and thoracic duct lymph (postoperative fistula). After one subject with chyluria ingested 40 g of corn oil, triglyceride excretion in urine was accompanied by an increased excretion of apoA-IV. 11.5 g of triglyceride and 81 mg of apoA-IV were recovered in the urine. In chylous urine 56% of apoA-IV was in the triglyceride-rich lipoproteins (chylomicrons and intestinal VLDL) and 44% in the d > 1.006-g/ml fraction. Normal plasma apoA-IV was 15.7±0.9 mg/dl (n = 14) whereas four subjects with abetalipoproteinemia had reduced levels 1.2, 7.6, 9.6, and 8.3 mg/dl, respectively. Lipid feeding in normal volunteers resulted in a rise in plasma apoA-IV (16.1±0.7 mg/dl to 18.5±0.7 mg/dl, n = 5, P < 0.01). In fasting plasma, 98% of apoA-IV was in the d > 1.21-g/ml fraction. In lipemic plasma, 10% of apoA-IV was associated with triglyceride-rich lipoproteins and 90% with the d > 1.21-g/ml fraction. Agarose column chromatography of fasting plasma confirmed that the bulk of plasma apoA-IV is free, unassociated with lipoproteins. These results demonstrate that apoA-IV is present in human intestinal epithelial cells and is secreted as a chylomicron and VLDL apoprotein. Within fasting plasma most of the apoA-IV is found free, unassociated with lipoproteins. After lipid ingestion apoA-IV is also found in plasma chylomicrons indicating that some apoA-IV remains associated with chylomicrons in plasma during chylomicron metabolism, although some may be transferred from the chylomicron surface.This publication has 37 references indexed in Scilit:
- Human Intestinal LipoproteinsJournal of Clinical Investigation, 1979
- Apoprotein A-I Synthesis in Normal Intestinal Mucosa and in Tangier DiseaseNew England Journal of Medicine, 1978
- Isolation and characterization of an apoprotein from the d<1.006 lipoproteins of human and canine lymph homologous with the rat A-IV apoproteinBiochemical and Biophysical Research Communications, 1978
- Metabolism of High-Density Lipoprotein Apolipoproteins in Tangier DiseaseNew England Journal of Medicine, 1978
- Isolation and characterization of two threonine-poor apolipoproteins of human plasma high density lipoproteinsBiochemistry, 1978
- Characterization of the apolipoproteins of rat plasma lipoproteinsBiochemistry, 1977
- Apoprotein B in fasting and postprandial human jejunal mucosa.Journal of Clinical Investigation, 1976
- The removal of cholesterol from aortic smooth muscle cells in culture and landschutz ascites cells by fractions of human high-density apolipoproteinBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1975
- A protein cofactor of lecithin:Cholesterol acyltransferaseBiochemical and Biophysical Research Communications, 1972
- A specific apoprotein activator for lipoprotein lipaseBiochemical and Biophysical Research Communications, 1970